Insights

IVD Tools Expansion Firalis specializes in developing In Vitro Diagnostic (IVD) tools based on clinically qualified biomarkers. Leveraging this expertise, there is a significant sales opportunity to expand the IVD tools portfolio to address emerging healthcare needs and diagnostic demands.

CRO Services Development The biomarker-related Contract Research Organization (CRO) services offered by Firalis, including Proteomics, Genomics/Transcriptomics, and Flow Cytometry, present a lucrative sales avenue. Targeting laboratories, biotech firms, and the pharmaceutical industry with these specialized services can drive revenue growth.

Cutting-Edge Sequencing Technology With the acquisition of the Illumina NovaSeq X Plus Sequencing System, Firalis has enhanced its capabilities in mRNA targeted gene sequencing. This advanced technology provides a competitive edge and offers sales opportunities to cater to the growing demand for precision medicine and genomic testing.

RUO Product Launches Firalis frequently launches Research-Use-Only (RUO) biomarker products like the Biopred Immuno-Inflammatory panel. Sales representatives can capitalize on these innovative product releases to engage with research institutions, pharmaceutical companies, and biotech startups seeking cutting-edge biomarker solutions.

Secure Funding Growth Securing substantial funding from Bpifrance and being recognized for innovative approaches positions Firalis for financial stability and growth. Sales professionals can leverage this financial backing to invest in sales and marketing efforts, expand market reach, and drive sales of biomarker products and services.

FIRALIS S.A. Tech Stack

FIRALIS S.A. uses 8 technology products and services including MySQL, Google Font API, Google Cloud, and more. Explore FIRALIS S.A.'s tech stack below.

  • MySQL
    Database
  • Google Font API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Google Maps
    Maps
  • SWFObject
    Miscellaneous
  • jQuery Mobile
    Mobile Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • Nginx
    Web Servers

Media & News

FIRALIS S.A.'s Email Address Formats

FIRALIS S.A. uses at least 1 format(s):
FIRALIS S.A. Email FormatsExamplePercentage
First.Last@firalis.comJohn.Doe@firalis.com
49%
First@firalis.comJohn@firalis.com
1%
First.Last@firalis.comJohn.Doe@firalis.com
49%
First@firalis.comJohn@firalis.com
1%

Frequently Asked Questions

Where is FIRALIS S.A.'s headquarters located?

Minus sign iconPlus sign icon
FIRALIS S.A.'s main headquarters is located at 35, Rue du Fort HUNINGUE, 68330 FR. The company has employees across 2 continents, including EuropeAsia.

What is FIRALIS S.A.'s phone number?

Minus sign iconPlus sign icon
You can contact FIRALIS S.A.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is FIRALIS S.A.'s official website and social media links?

Minus sign iconPlus sign icon
FIRALIS S.A.'s official website is firalis.com and has social profiles on LinkedIn.

What is FIRALIS S.A.'s SIC code NAICS code?

Minus sign iconPlus sign icon
FIRALIS S.A.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does FIRALIS S.A. have currently?

Minus sign iconPlus sign icon
As of April 2025, FIRALIS S.A. has approximately 30 employees across 2 continents, including EuropeAsia. Key team members include Chief Operating Officer: F. F.Head Of Testing And Methods Validation: A. M.Head Of Clinical Operations: R. M.. Explore FIRALIS S.A.'s employee directory with LeadIQ.

What industry does FIRALIS S.A. belong to?

Minus sign iconPlus sign icon
FIRALIS S.A. operates in the Biotechnology Research industry.

What technology does FIRALIS S.A. use?

Minus sign iconPlus sign icon
FIRALIS S.A.'s tech stack includes MySQLGoogle Font APIGoogle CloudGoogle MapsSWFObjectjQuery MobileX-Content-Type-OptionsNginx.

What is FIRALIS S.A.'s email format?

Minus sign iconPlus sign icon
FIRALIS S.A.'s email format typically follows the pattern of . Find more FIRALIS S.A. email formats with LeadIQ.

When was FIRALIS S.A. founded?

Minus sign iconPlus sign icon
FIRALIS S.A. was founded in 2008.
FIRALIS S.A.

FIRALIS S.A.

Biotechnology Research68330, France11-50 Employees

Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM).

1) BIOMARKER PRODUCTS
Firalis develops BM-based diagnostic, prognostic and theranostic tools:
● RUO Kits (Research-Use-Only), based on validated innovative biomarkers
● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers

2) BIOMARKER R&D
● Development of proprietary BMs 
   - Cardiovascular, Inflammatory, Autoimmune and Neurology
● Drug Safety & Drug Efficacy
● Patient Stratification
● Personalized Medicine

3) BIOMARKER-RELATED CRO SERVICES
BM Discovery for laboratories, biotechs and pharmaceutical industry:
- Proteomics: Soluble biomarker measurements with several immunoassays technologies (ELISA, multiplex and high sensitivity platforms such as Luminex® BioPlex 200™, Meso Scale Discovery®, Singulex Erenna®, Protein Simple Ella™, Olink and Siemens Dimension® EXL™ 200)
- Genomics/Transcriptomics: Targeted sequencing of miRNA and mRNA (HTG EdgeSeq), lncRNA screening via Firalis proprietary platform, Next-Generation Sequencing (NGS) services (RNA-Seq, whole genome and exome sequencing, etc.) and qPCR/microfluidic qPCR (Gene Expression, SNP, CNV, etc.)
- Flow Cytometry: Immunophenotyping of preclinical and clinical samples, monitoring of pharmacodynamics on target cells in response to treatment and biomarker discovery
- Assay development and validation on various platforms, development of critical reagents (antibodies and proteins)
- Biobanking and sample repository services supported by LIMS
- Data analysis using multi-parametric statistics and development of predictive models
- Support of regulatory activities related to biomarker qualification with Health Authorities (FDA/EMA)
- Quality environment (ISO 9001, ISO 13485 (GMP), ISO 17025 (GLP/GCLP))

For more information please visit our website.

Section iconCompany Overview

Headquarters
35, Rue du Fort HUNINGUE, 68330 FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $100M$1B

    FIRALIS S.A.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    FIRALIS S.A.'s revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.